Skip to main content
Top

Current Treatment Options in Oncology

Issue 12/2017

Content (7 Articles)

Upper Gastrointestinal Cancers (L Rajdev, Section Editor)

The Role of Systemic Therapy in Resectable Gastric and Gastro-oesophageal Junction Cancer

Elizabeth Cartwright, David Cunningham

Upper Gastrointestinal Cancers (L Rajdev, Section Editor)

The Multidisciplinary Approach to Localized Pancreatic Adenocarcinoma

Hiral D. Parekh, Jason Starr, Thomas J. George Jr.

Upper Gastrointestinal Cancers (L Rajdev, Section Editor)

Update in the Therapy of Advanced Neuroendocrine Tumors

Inbal Uri, Shani Avniel-Polak, David J. Gross, Simona Grozinsky-Glasberg

Leukemia (PH Wiernik, Section Editor)

Treatment of Richter’s Syndrome

Adalgisa Condoluci, Davide Rossi

Leukemia (PH Wiernik, Section Editor)

Diagnosis and Treatment of Aplastic Anemia

Scott A. Peslak, Timothy Olson, Daria V. Babushok

Lung Cancer (HA Wakelee, Section Editor)

Anaplastic Lymphoma Kinase Testing: IHC vs. FISH vs. NGS

Xiaomin Niu, Jody C. Chuang, Gerald J. Berry, Heather A. Wakelee

Neuro-oncology (GJ Lesser, Section Editor)

Combined Vertebral Augmentation and Radiofrequency Ablation in the Management of Spinal Metastases: an Update

Ning Mao Kam, Julian Maingard, Hong Kuan Kok, Dinesh Ranatunga, Duncan Brooks, William C. Torreggiani, Peter L. Munk, Michael J. Lee, Ronil V. Chandra, Hamed Asadi

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine